Impact of elevated aspartate and alanine aminotransferase on metabolic syndrome and its components among adult people living in Ningxia, China
- PMID: 29062997
- PMCID: PMC5643566
- DOI: 10.1016/j.cdtm.2015.06.004
Impact of elevated aspartate and alanine aminotransferase on metabolic syndrome and its components among adult people living in Ningxia, China
Abstract
Objective: Metabolic syndrome (MS) is a combination of medical disorders that increase the risk for cardiovascular disease and diabetes mellitus. It suggests an association between an elevated serum aminotransferase level and MS. Little data show the relationship between the levels of serum aminotransferase and the incidence of MS in Ningxia, China.
Methods: A total of 5415 subjects who received medical health checkups from 2007 to 2009 were enrolled in the study. The participants were interviewed by trained health workers under a structured questionnaire. MS was defined according to the modified ATPIII criteria for Asian Americans by the American Heart Association (AHA-ATP III).
Results: The prevalence of elevated aspartate aminotransferase (AST) and ALT (>40 U/L) were 7.1% and 22.2% in males, and 2.1% and 4.8% in females respectively. The prevalence of MS was 32.1% in males and 15.4% in females. The components of MS were significantly more in the group with elevated aminotransferase levels than in the group with normal aminotransferase levels. The odds ratios (95% CI) for elevated AST were 1.90 (1.49, 2.42), 2.59 (2.01, 3.39), 1.68 (1.32, 2.15), and 1.81 (1.36, 2.42) in the adults with abdominal obesity, high serum triglycerides levels, high blood pressure, and high plasma glucose levels respectively. After adjustment for age, the odds ratios (95% CI) for elevated ALT were 3.08 (2.63, 3.61), 4.30 (3.64, 5.08), 1.26 (1.08, 1.48), 2.16 (1.93, 2.65) and 2.38 (1.96, 2.87) in adults with abdominal obesity, high serum triglycerides levels, low serum high-density lipoproteincholesterol (HDL-C), high blood pressure, and high plasma glucose levels respectively. The odds ratios (95% CI) for elevated AST were 1.67 (1.06, 2.63), 2.28 (1.46, 3.63), 2.59 (1.59, 4.21) and for elevated ALT 2.02 (1.50, 2.73), 2.68 (1.96, 3.65), 3.94 (2.86, 5.43) for the subjects with 1, 2, and ≥3 risk factors after adjustment for age, gender, and BMI.
Conclusion: The serum aminotransferase levels were higher in males compared to females, and serum ALT level was more closely associated with MS than the AST level in adults in Ningxia, China. With an increasing the number of components of MS, the aminotransferase levels and the risks for elevated aminotransferase increase, whereas the AST/ALT ratios decrease.
Keywords: Metabolic syndrome; Odds ratios; Serum aminotransferase.
Similar articles
-
[Study on the relationship between transaminase activity and metabolic syndrome in Hui and Han nationality of Ningxia Province].Wei Sheng Yan Jiu. 2016 Nov;45(6):938-944. Wei Sheng Yan Jiu. 2016. PMID: 29903077 Chinese.
-
Prevalence and associated metabolic factors of fatty liver disease in the elderly.Exp Gerontol. 2013 Aug;48(8):705-9. doi: 10.1016/j.exger.2013.05.059. Epub 2013 May 27. Exp Gerontol. 2013. PMID: 23721951
-
[Study on the relationship between WBC count levels and type 2 diabetes mellitus in Hui and Han nationality of Ningxia].Wei Sheng Yan Jiu. 2015 May;44(3):387-92. Wei Sheng Yan Jiu. 2015. PMID: 26137615 Chinese.
-
[Association between occupational stress and aminotransferase activity in patients with metabolic syndrome].Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2016 Dec 20;34(12):911-916. doi: 10.3760/cma.j.issn.1001-9391.2016.12.007. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2016. PMID: 28241679 Chinese.
-
AST to ALT ratio and arterial stiffness in non-fatty liver Japanese population:a secondary analysis based on a cross-sectional study.Lipids Health Dis. 2018 Dec 3;17(1):275. doi: 10.1186/s12944-018-0920-4. Lipids Health Dis. 2018. PMID: 30509277 Free PMC article. Review.
References
-
- Grundy S.M. Obesity, metabolic syndrome and cardiovascular disease. J Clin Endocrinol Metab. 2004;89:2595–2600. - PubMed
-
- Schindhelm R.K., Dekker J.M., Nijpels G. Alanine aminotransferase and the 6-year risk of the metabolic syndrome in Caucasian males and females: the Hoorn Study. Diabet Med. 2007;24:430–435. - PubMed
-
- Vozarova B., Stefan N., Lindsay R.S. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes. 2002;51:1889–1895. - PubMed
-
- Sung K.C., Ryan M.C., Kim B.S., Cho Y.K., Kim B.I., Reaven G.M. Relationships between estimates of adiposity, insulin resistance, and nonalcoholic fatty liver disease in a large group of nondiabetic Korean adults. Diabetes Care. 2007;30:2113–2118. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources